Literature DB >> 20108276

Structure of the complex of [Ru(tpm)(dppz)py](2+) with a B-DNA oligonucleotide - a single-substituent binding switch for a metallo-intercalator.

Philip Waywell1, Veronica Gonzalez, Martin R Gill, Harry Adams, Anthony J H M Meijer, Mike P Williamson, James A Thomas.   

Abstract

We report the synthesis of three new complexes related to the achiral [Ru(tpm)(dppz)py](2+) cation (tpm=tripyridazole methane, dppz=dipyrido[3,2-a:2',3'-c]phenazine, py=pyridine) that contain an additional single functional group on the monodentate ancillary pyridyl ligand. Computational calculations indicate that the coordinated pyridyl rings are in a fixed orientation parallel to the dppz axis, and that the electrostatic properties of the complexes are very similar. DNA binding studies on the new complexes reveal that the nature and positioning of the functional group has a profound effect on the binding mode and affinity of these complexes. To explore the molecular and structural basis of these effects, circular dichroism and NMR studies on [Ru(tpm)(dppz)py]Cl(2) with the octanucleotides d(AGAGCTCT)(2) and d(CGAGCTCG)(2), were carried out. These studies demonstrate that the dppz ligand intercalates into the G(2)-A(3) step, with {Ru(tpm)py} in the minor groove. They also reveal that the complex intercalates into the binding site in two possible orientations with the pyridyl ligand of the major conformer making close contact with terminal base pairs. We conclude that substitution at the 2- or 3-position of the pyridine ring has little effect on binding, but that substitution at the 4-position drastically disrupts intercalative binding, particularly with a 4-amino substituent, because of steric and electronic interactions with the DNA. These results indicate that complexes derived from these systems have the potential to function as sequence-specific light-switch systems.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20108276     DOI: 10.1002/chem.200901758

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  6 in total

1.  Photochemically active DNA-intercalating ruthenium and related complexes - insights by combining crystallography and transient spectroscopy.

Authors:  Christine J Cardin; John M Kelly; Susan J Quinn
Journal:  Chem Sci       Date:  2017-04-12       Impact factor: 9.825

2.  An 111In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells.

Authors:  Martin R Gill; Michael G Walker; Sarah Able; Ole Tietz; Abirami Lakshminarayanan; Rachel Anderson; Rod Chalk; Afaf H El-Sagheer; Tom Brown; Jim A Thomas; Katherine A Vallis
Journal:  Chem Sci       Date:  2020-08-10       Impact factor: 9.969

3.  Ruthenium(II)-Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium Homeostasis.

Authors:  Jakub Cervinka; Alberto Gobbo; Lorenzo Biancalana; Lenka Markova; Vojtech Novohradsky; Massimo Guelfi; Stefano Zacchini; Jana Kasparkova; Viktor Brabec; Fabio Marchetti
Journal:  J Med Chem       Date:  2022-08-01       Impact factor: 8.039

4.  Initial DNA interactions of the binuclear threading intercalator Λ,Λ-[μ-bidppz(bipy)4Ru2]4+: an NMR study with [d(CGCGAATTCGCG)]2.

Authors:  Lisha Wu; Anna Reymer; Cecilia Persson; Krzysztof Kazimierczuk; Tom Brown; Per Lincoln; Bengt Nordén; Martin Billeter
Journal:  Chemistry       Date:  2013-02-28       Impact factor: 5.236

5.  Tris-[4-(di-methyl-amino)-pyridine][tris(pyra-zol-1-yl)methane]--ruthenium(II) bis-(hexa-fluorido-phosphate) diethyl ether monosolvate.

Authors:  Benjamin J Coe; James Raftery; Daniela Rusanova
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-09-21

6.  Structural studies on dinuclear ruthenium(II) complexes that bind diastereoselectively to an antiparallel folded human telomere sequence.

Authors:  Tom Wilson; Paulo J Costa; Vítor Félix; Mike P Williamson; Jim A Thomas
Journal:  J Med Chem       Date:  2013-10-23       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.